HSBC Holdings
CTKB icon

HSBC Holdings’s Cytek Biosciences CTKB Stock Holding History

HSBC Holdings’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.7K Buy
+19,734
New +$84.2K ﹤0.01% 2823
2025
Q3 		– Sell
-15,006
Closed -$52.1K – 2779
2025
Q2 		$52.1K Buy
15,006
+1,243
+9% +$4.14K ﹤0.01% 2929
2025
Q1 		$55.3K Sell
13,763
-355
-3% -$1.84K ﹤0.01% 2892
2024
Q4 		$92.5K Sell
14,118
-1,288
-8% -$7.67K ﹤0.01% 2902
2024
Q3 		$86K Buy
15,406
+1,699
+12% +$9.63K ﹤0.01% 2820
2024
Q2 		$75.4K Buy
13,707
+247
+2% +$1.48K ﹤0.01% 2779
2024
Q1 		$90.3K Buy
+13,460
New +$106K ﹤0.01% 2864

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HSBC Holdings's CTKB Position: Q2 2026 in Review

HSBC Holdings opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 19,734 shares worth $85.7K. The stake represents ﹤0.01% of the portfolio and ranks #2823 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in CTKB as recently as Q2 2025.

HSBC Holdings first reported a position in CTKB in Q1 2024 and has held it in 7 quarters since. The position peaked at $92.5K in Q4 2024. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • HSBC Holdings held 19,734 shares of Cytek Biosciences worth $85.7K as of Q2 2026.
  • Cytek Biosciences was a new HSBC Holdings position in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2823 holding.
  • HSBC Holdings first reported a position in Cytek Biosciences in Q1 2024 and has held it in 7 quarters since.
  • HSBC Holdings's Cytek Biosciences position peaked at $92.5K in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.